Turner Kathy V
SEC CIK 1740719 · EDGAR
BoughtSold
Most active insiders at ELAN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kurzius Lawrence Erik | Dir | $1.15M | — |
| 2 | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | $578.3K | — |
| 3 | VanHimbergen Robert M | EVP, CFO | $247.3K | — |
| 4 | Herendeen Paul | Dir | $236.8K | — |
| 5 | Modi Rajeev A. | SEE REMARKS | $195.9K | — |
| 6 | Harrington Michael J | Dir | $109.1K | — |
| 7 | O'Neill Shiv | GC AND CORP SEC | $94.3K | — |
| 8 | McArdle Grace | EVP, MANUFACTURING AND QUALITY | — | — |
| 9 | de Brabander Ellen | SEE REMARKS | — | — |
| 10 | Ma Stacey | Dir | — | — |
Turner Kathy V made no open-market trades at ELAN in the last 12 months.
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-03 | 2024-11-29 | ELAN | Elanco Animal Health Inc | Turner Kathy V | Dir | A - Grant | $0.00 | +13.8K | 13.8K | New | $0 | |
| DM | 2023-02-17 | 2023-02-15+ | IDXX | Idexx Laboratories | Turner Kathy V | SVP | S - Sale+OE | $510.08 | -1,010 | 7,380 | -12% | -$515.2K |
| D | 2023-02-17 | 2023-02-16 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | M - OptEx | $79.54 | +10 | 7,390 | +0.1% | +$795.40 |
| D | 2023-02-17 | 2023-02-15 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | A - Grant | $79.54 | +1,000 | 8,380 | +14% | +$79.5K |
| DM | 2023-02-16 | 2023-02-14 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | M - OptEx | $58.23 | +2,732 | 9,380 | +41% | +$159.1K |
| DM | 2023-02-16 | 2023-02-14 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | S - Sale+OE | $504.59 | -2,000 | 7,490 | -21% | -$1.01M |
| D | 2023-02-16 | 2023-02-14 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | F - Tax | $503.65 | -293 | 7,380 | -4% | -$147.6K |
| D | 2023-02-13 | 2023-02-09 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | M - OptEx | $79.54 | +1,000 | 7,941 | +14% | +$79.5K |
| D | 2023-02-13 | 2023-02-09 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | S - Sale+OE | $505.04 | -1,000 | 6,941 | -13% | -$505.0K |
| D | 2022-12-05 | 2022-12-01 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | S - Sale+OE | $436.00 | -3,000 | 6,923 | -30% | -$1.31M |
| D | 2022-12-05 | 2022-12-01 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | M - OptEx | $141.60 | +3,000 | 9,923 | +43% | +$424.8K |
| DM | 2022-11-14 | 2022-11-10+ | IDXX | Idexx Laboratories | Turner Kathy V | SVP | S - Sale+OE | $426.70 | -13.9K | 6,923 | -67% | -$5.92M |
| DM | 2022-11-14 | 2022-11-10+ | IDXX | Idexx Laboratories | Turner Kathy V | SVP | M - OptEx | $189.23 | +13.9K | 12.2K | New | +$2.63M |
| DM | 2022-02-22 | 2022-02-18 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | M - OptEx | $91.73 | +2,180 | 6,886 | +46% | +$200.0K |
| DM | 2022-02-16 | 2022-02-14 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | M - OptEx | $0.00 | +851 | 5,001 | +21% | $0 |
| D | 2022-02-16 | 2022-02-14 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | F - Tax | $505.53 | -295 | 4,706 | -6% | -$149.1K |
| D | 2021-09-02 | 2021-08-31 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | M - OptEx | $79.54 | +1,256 | 4,131 | +44% | +$99.9K |
| DM | 2021-08-31 | 2021-08-27+ | IDXX | Idexx Laboratories | Turner Kathy V | SVP | M - OptEx | $77.87 | +2,526 | 5,125 | +97% | +$196.7K |
| DM | 2021-08-31 | 2021-08-27+ | IDXX | Idexx Laboratories | Turner Kathy V | SVP | S - Sale+OE | $686.21 | -2,526 | 2,875 | -47% | -$1.73M |
| A | 2021-08-31 | 2021-05-28 | IDXX | Idexx Laboratories | Turner Kathy V | SVP | S - Sale | $558.44 | -2,000 | 2,866 | -41% | -$1.12M |
Purchase Sale Sale after option exercise All abbreviations